AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bivacard 250mg Injection

Prescription Icon
Prescription Required

Marketer

Biocon

Salt Composition

Bivalirudin (250mg)

Overview Bivacard 250mg Injection

Bivacard 250mg Injection, an anticoagulant medication, prevents and treats blood clots, thus lowering the risk of stroke and heart attack. It's indicated for venous and arterial thrombosis prevention, particularly in patients with atrial fibrillation and those recovering from hip or knee replacements. Administered intravenously by a healthcare professional, this injection helps reduce clot formation in the legs, lungs, brain, and heart. Lifestyle modifications, including a balanced diet, regular exercise, smoking cessation, and weight management, further mitigate clot risk. Common side effects include headache, thrombocytopenia, and fever; increased bleeding tendencies (e.g., nosebleeds, easy bruising) necessitate caution with sharp objects. Consult your physician if you have impaired liver or kidney function, are currently bleeding, use other anticoagulants, or are breastfeeding; this medication may not be appropriate for all individuals. Unlike some anticoagulants, routine PT-INR monitoring isn't necessary.

Uses of Bivacard 250mg Injection

Managing and preventing thrombosis

Major Benefits of Bivacard 250mg Injection:

Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Bivacard 250mg Injection:

  • Low blood platelets
  • Headache
  • Fever
  • Bleeding

How to use Bivacard 250mg Injection:

This medication will be administered by your healthcare provider; please do not attempt self-medication.

How Bivacard 250mg Injection works:

Cardobiv 250mg injection is a medication that inhibits blood clot development, acting as a preventative against potentially dangerous thrombi.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Bivacard 250mg Injection should not be used together.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable form of Bivacard, 250mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Bivacard 250mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingNOT RELEVANT

Inapplicable, given that Bivacard 250mg Injection is administered exclusively in the inpatient setting.

KidneyKidneyCAUTION

Caution is advised when administering Bivacard 250mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Bivacard 250mg Injection is contraindicated for patients exhibiting severe kidney disease or undergoing dialysis treatment.

LiverLiverSAFE IF PRESCRIBED

The use of Bivacard 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.

What if you forget to take Bivacard 250mg Injection :

NA

Facts to Know About Bivacard 250mg Injection

LabelValue
Type of Compound Short chains of amino acids
Potential for Dependence None.
Type of Medication HEART
Mechanism of Action Thrombin inhibitor for injection

FAQs on Bivacard 250mg Injection

Bivacard 250mg Injection differs from other blood thinners in its typically negligible impact on liver function. Prolonged administration of Bivacard 250mg Injection, however, might heighten the risk of minor liver damage in individuals with pre-existing elevated liver enzyme levels. The likelihood of such complications remains less than that associated with alternative anticoagulants. Prior liver conditions should be disclosed to your physician before commencing treatment with this medication.
Concurrent use of Bivacard 250mg Injection and alcohol may enhance the medication's anticoagulant properties, raising the risk of hemorrhage. Alcohol consumption can also contribute to peptic ulcers, further increasing bleeding potential. Therefore, abstaining from alcohol during treatment is advisable. Seek immediate medical attention should any bleeding occur.
Administering Bivacard 250mg Injection requires storage at room temperature, specifically 20°–25°C (68°–77°F). Keep the injection within its original packaging and avoid freezing. Maintain a dry environment and shield the medication from both moisture and light.
The 250mg Bivacard injection lessens the likelihood of blood clot formation in the leg, lung, heart, and brain vasculature. You might not notice any immediate effects from the 250mg Bivacard injection. Nevertheless, continue using this medication as directed by your physician to ensure complete therapeutic benefit.
Individuals with a history of abnormal bleeding, or those exhibiting an allergy to Bivacard 250mg Injection, must refrain from its use. The injection is contraindicated in patients possessing prosthetic heart valves. Consequently, disclose any past or planned cardiac valve replacement procedures to your physician. Furthermore, this medication is unsuitable for individuals suffering from severe renal impairment.
Bivacard 250mg Injection can elevate the likelihood of hemorrhage. Exercise caution when engaging in potentially hazardous activities that could result in injury or bleeding. Report any unusual bruising or bleeding to your physician promptly.
Hair loss is not a typical side effect of Bivacard 250mg Injection. While infrequent cases linking the injection to hair loss have been documented, it's crucial to seek medical advice if you experience this symptom during treatment. Your physician can determine if other factors are contributing to your hair loss.
Bivacard 250mg Injection
7,036
MRP 8,571
17% off